Toggle navigation
Home
Search
Services
Blog
Contact
About
Development-266030017
Acambis, Inc., Cambridge, MA, United States
Search grants from Acambis, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Targeting brain inflammation and neurocognitive dysfunction in sepsis
Function and mechanisms of extracellular microRNAs in sepsis-induced lung injury
Studies in Translational Regenerative Medicine
Young Drivers Intervention Study
Nurse Practitioner and/OR Nurse Midwifery Program
Recently added grants:
PGI2 augments Treg function
Role of T cell-derived amphiregulin in recovery from influenza virus infection
Genital Chlamydia spreading to the gastrointestinal tract promotes chlamydial pathogenicity in the upper genital tract
snoRNA31 is critical for human cell-intrinsic immunity to HSV-1 in the central nervous system
Measuring Chronic Pain Impact
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI030017-002
Application #
6829008
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Acambis, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Related projects
NIH 2006
N01 AI
Development-266030017-266030017
/ Acambis, Inc.
NIH 2004
N01 AI
Development-266030017
/ Acambis, Inc.
NIH 2003
N01 AI
Development-266030017
/ Acambis, Inc.
Comments
Be the first to comment on this grant